Filing Details

Accession Number:
0001209191-10-019337
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-30 13:00:00
Reporting Period:
2010-03-26
Filing Date:
2010-03-30
Accepted Time:
2010-03-30 17:45:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1390478 Rxi Pharmaceuticals Corp RXII Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1249422 S Stephen Galliker C/O Rxi Pharmaceuticals Corporation
60 Prescott Street
Worcester MA 01605
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-03-26 15,000 $5.54 10,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct